Skip to main content
. 2022 Feb 1;14(3):765. doi: 10.3390/cancers14030765
5-caC 5-carboxylcytosine
5-fC 5-formylcytosine
5-FU 5-fluorouracil
5-hmC 5-hydroxymethylcytosine
5-hmU 5-hydroxymethyluracil
5-mC 5-methylcytosine
5-OHC 5-hydroxycytosine
5-OHU 5-hydroxyuracil
8oxoA 7,8-dihydro-8-oxoadenine
AP Apurinic/Apyrimidinic
AR Androgen Receptor
BAs Bile Acids
BER Base Excision Repair
BrC 5-bromocytosine
CBP CREB-binding Protein
ClU 5-chlorouracil
CRC Colorectal cancer
DNMT DNA methyltransferase
ER Estrogen Receptor
eRNAs enhancer RNAs
ESCC Esophageal Squamous Cell Carcinoma
ɛC 3,N4-ethenocytosine
fU 5-formyluracil
FXR Farnesoid X Receptor
GADD45a Growth Arrest and DNA damage-inducible Protein Alpha
GR Glucocorticoid Receptor
HB Hepatoblastoma
HCC Hepatocellular Carcinoma
Hic1 Hypermethylated in Cancer 1
mESCs Mouse Embryonic Stem Cells
NMSC Nonmelanoma Skin Cancer
PPAR Peroxisome Proliferator-Activated Receptor
PR Progesterone Receptor
RARα Retinoic Acid Receptor α
RXRα Retinoid X Receptor α
SAM S-adenosylmethionine
SNPs Single Nucleotide Polymorphisms
TDG Thymine DNA Glycosylase
Tdg cKO Conditional TDG Knockout
TET Ten Eleven Translocation
tg thymine glycol
TR Thyroid Hormone Receptor
UDG Uracil DNA Glycosylase
UHRF1 Ubiquitin-like containing PHD and RING finger domains 1
VDR Vitamin D3 Receptor